Tankyrase-1 Inhibitors

Tankyrase-1 inhibitors represent a distinctive class of chemical compounds that have gained significant attention due to their vital role in modulating the Wnt/β-catenin signaling pathway, a crucial molecular pathway that regulates various cellular processes including embryogenesis, tissue homeostasis, and proliferation. Tankyrase-1, a poly(ADP-ribose) polymerase enzyme, is a central component of this signaling pathway, acting as a regulator of β-catenin degradation. Tankyrase-1 achieves this by mediating the poly-ADP-ribosylation of AXIN, a scaffold protein that forms a complex with adenomatous polyposis coli (APC), glycogen synthase kinase 3β (GSK3β), and β-catenin, thereby facilitating the degradation of β-catenin. The latter is a key event in the canonical Wnt signaling cascade, impacting gene transcription and cellular fate determination. Tankyrase-1 inhibitors are small molecules designed to selectively block the enzymatic activity of Tankyrase-1, thus stabilizing AXIN and subsequently promoting the degradation of β-catenin. This regulation of the Wnt/β-catenin pathway has far-reaching effects on cellular processes and has implications in numerous physiological and pathological contexts.The development and study of Tankyrase-1 inhibitors have unveiled intricate insights into the intricate mechanisms governing cell signaling and gene expression. By blocking the degradation of β-catenin, these inhibitors have shown potential in affecting cellular proliferation, stem cell maintenance, and tissue regeneration. Additionally, they have emerged as valuable tools for dissecting the role of Wnt/β-catenin signaling in various diseases, including cancer, given that aberrant pathway activation is a hallmark of numerous malignancies. The structural diversity within the Tankyrase-1 inhibitor class highlights the ongoing efforts to design compounds with improved potency, selectivity, and pharmacokinetic properties.